OLVIG
EXAS

Oliver Lagore Vanvalin Investment Group’s Exact Sciences EXAS Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$2.17K Buy
+50
New +$2.54K ﹤0.01% 548
2024
Q4 		$2.81K Hold
50
– – ﹤0.01% 559
2024
Q3 		$3.41K Hold
50
– – ﹤0.01% 535
2024
Q2 		$2.11K Hold
50
– – ﹤0.01% 595
2024
Q1 		$3.45K Hold
50
– – ﹤0.01% 564
2023
Q4 		$3.7K Sell
50
-26
-34% -$1.7K ﹤0.01% 566
2023
Q3 		$5.18K Buy
76
+26
+52% +$2.21K ﹤0.01% 545
2023
Q2 		$4.7K Hold
50
– – ﹤0.01% 575
2023
Q1 		$3.39K Hold
50
– – ﹤0.01% 538
2022
Q4 		$2.48K Hold
50
– – ﹤0.01% 539
2022
Q3 		$2K Hold
50
– – ﹤0.01% 520
2022
Q2 		$2K Buy
50
+25
+100% +$1.34K ﹤0.01% 492
2022
Q1 		$2K Buy
+25
New +$1.83K ﹤0.01% 501

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's EXAS Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Exact Sciences (EXAS) in Q2 2025: 50 shares worth $2.17K. The stake represents ﹤0.01% of the portfolio and ranks #548 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in EXAS as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in EXAS in Q1 2022 and has held it in 13 quarters since. The position peaked at $5.18K in Q3 2023. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 50 shares of Exact Sciences worth $2.17K as of Q2 2025.
  • Exact Sciences was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Exact Sciences made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #548 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Exact Sciences in Q1 2022 and has held it in 13 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Exact Sciences position peaked at $5.18K in Q3 2023.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.